AI Powered Precision Oncology
AI Guided Precision Oncology
Built for Africa
Accurate
We are building the first AI OS designed to close the cancer survival gap for African women.We are moving treatment from standardized care to predictive, precision care at scale.
Explore Platform →
87%
Confidence
Malignant Tumor Detected
AI model has identified a malignant breast tumor with high confidence. Immediate consultation with an oncologist is recommended.
Tumor ClassificationInvasive Ductal Carcinoma
Predicted StageStage IIB
Chemotherapy Resistance Risk68% Moderate-High
5-Year Survival Rate76% with treatment
Ki-67 IndexHigh
Proliferation Rate: 78%
HER2 StatusPositive
Expression Level: 85%
ER EstrogenPositive
Expression Level: 72%
PR ProgesteronePositive
Expression Level: 65%
95% Prediction analysis
Clinically validated
Our News
Discover how Keti AI is changing the lives of people. Stay up to date with our latest research and announcements.
Our Partners